3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
16
Carcinoma, Renal Cell
12
Carcinoma, Non-Small-Cell Lung
9
Neoplasm Metastasis
6
Carcinoma, Transitional Cell
4
Neoplasms
3
Lung Neoplasms
3
Clear-cell metastatic renal cell carcinoma
3
Carcinoma, Hepatocellular
3
Urogenital Neoplasms
2
Urinary Bladder Neoplasms
2
Urethral Neoplasms
2
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Prostatic Neoplasms
2
Penile Neoplasms
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Nasopharyngeal Carcinoma
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Liver Neoplasms
2
Leukemia, Myeloid, Acute
2
Kidney Neoplasms
2
Glioblastoma
2
Colorectal Neoplasms
2
Carcinoma, Basal Cell
2
Carcinoma
2
Brain Neoplasms
2
Vulvar Neoplasms
1
Interventions
Cisplatin
4
Cetuximab
4
pembrolizumab
3
Radiotherapy
3
cemiplimab
2
Surveys and Questionnaires
2
Magnetic Resonance Spectroscopy
2
Carboplatin
2
olaparib
1
niraparib
1
fludarabine
1
dostarlimab
1
calcipotriene
1
avelumab
1
atezolizumab
1
alpha-2'-deoxythioguanosine
1
aldesleukin
1
Watchful Waiting
1
Tiragolumab
1
Surgical Procedures, Operative
1
Standard of Care
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Radiosurgery
1
Platinum
1
Phlebotomy
1
Paclitaxel
1
Nivolumab
1
Lidocaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
Ipilimumab
×
30 days
×
Clear all
No trials found.